Cargando…
Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb(®) adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb(®) adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several therapeutic drugs....
Autores principales: | Biever, Paul, Staudacher, Dawid L., Sommer, Michaela J., Triebel, Hannah, Neukamm, Merja A., Bode, Christoph, Supady, Alexander, Lother, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953359/ https://www.ncbi.nlm.nih.gov/pubmed/33710753 http://dx.doi.org/10.1002/prp2.743 |
Ejemplares similares
-
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
por: Lang, Corinna N., et al.
Publicado: (2020) -
Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019) -
Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation
por: Bemtgen, Xavier, et al.
Publicado: (2021) -
Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023) -
Fatal air embolism as complication of percutaneous dilatational tracheostomy on venovenous extracorporeal membrane oxygenation, two case reports
por: Lother, Achim, et al.
Publicado: (2016)